Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AACR, abnormally, absorption, algorithm, Anderson, Austria, billion, Bloomberg, bromo, bystander, cardiotoxicity, chance, characteristic, chemoradiotherapy, cleared, clock, constipation, contrast, COSO, craniotomy, crossed, customer, debulking, delivery, departmental, dexamethasone, disorganized, distance, dormant, dying, ECOG, edema, element, eleventh, endorse, Erlotinib, expedient, fat, fixed, graph, hallmark, HCC, hereof, Houston, HR, incidence, infrequent, inhibitor, IPM, irregular, irrespective, kidney, language, Lastly, lesion, literally, MAESTRO, master, mathematical, MD, muscle, ofMetastAtic, outgrowing, perfusion, persuasive, placebo, PNET, pooled, postoperative, predominately, proliferating, proliferative, prolonged, proteasome, quiescent, radiotherapy, RANO, reinvestment, reside, revealed, Roche, Sanofi, SARC, Serono, serum, standalone, strong, STS, subtopic, surgical, thereon, ulceration, uncommon, undelivered, unregulated, untargeted, variation, Vienna, virtue, vital
Removed:
acid, added, adjacent, alkylator, anal, Asian, Bank, beneath, Bioscience, borrow, borrowed, borrowing, bothersome, canceled, cancelled, cellular, chaotic, closing, collateral, composed, comprising, consistently, conversion, crosslinker, cumulatively, deferral, deficient, deoxyribonucleic, dibromo, died, dissolution, dissolved, distant, ectopic, eleven, eliminated, enable, enhance, Erbitux, esophageal, evaluable, FASB, finalization, footage, forfeited, forward, fourteen, fractional, Governance, grow, half, highlighted, history, hormone, hypoxically, implanted, implementing, incremental, initiate, Japan, JDC, leaving, lieu, loan, masked, mice, mouse, newly, Nominating, Novacea, NSCLC, numerousin, observing, optimized, originally, orthotopic, par, PCT, PD, permission, permitted, planning, PR, preferentially, principle, prospectively, prostatic, PRs, RECIST, reclassification, reclassifying, recommended, refractory, relapsed, released, repaid, representing, repriced, repricing, repurchased, restricted, retainer, reversible, SAB, SD, sensitivity, served, settled, seventeen, shareholder, Silicon, slowly, SRI, stopped, taxol, thyroid, Tirapazamine, transition, transitional, twenty, understand, unexercisable, utilizing, Valley, vote, weekly, xenograft
Filing tables
Filing exhibits
Related press release
MTEM similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-174844, No. 333-169689, 333-162719 and 333-153475) and Registration Statement on Form S-8 (No. 333-180149, No. 333-173047, No. 333-167260, 333-164865, No. 333-156733, No. 333-126276, No. 333-134598, and No. 333-143130) of Threshold Pharmaceuticals, Inc. of our report dated March 24, 2011 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 7, 2013